Insider Buying: Talphera (NASDAQ:TLPH) Insider Acquires $28,350.00 in Stock

Talphera, Inc. (NASDAQ:TLPH) insider Shakil Aslam purchased 35,000 shares of the company’s stock in a transaction dated Thursday, February 12th. The stock was bought at an average price of $0.81 per share, with a total value of $28,350.00. Following the completion of the transaction, the insider directly owned 83,178 shares of the company’s stock, valued at approximately $67,374.18. This represents a 72.65% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link.

Talphera Stock Performance

Shares of Talphera stock opened at $0.78 on Monday. The business’s 50 day moving average price is $1.00 and its 200 day moving average price is $0.99. The company has a market cap of $36.20 million, a price-to-earnings ratio of -2.04 and a beta of 0.46. Talphera, Inc. has a one year low of $0.38 and a one year high of $1.57.

Analyst Ratings Changes

Several research analysts have recently weighed in on the stock. Weiss Ratings reissued a “sell (d-)” rating on shares of Talphera in a research report on Wednesday, January 21st. Wall Street Zen raised shares of Talphera to a “hold” rating in a research note on Saturday, November 1st. One investment analyst has rated the stock with a Buy rating and one has issued a Sell rating to the company. According to MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $6.00.

Hedge Funds Weigh In On Talphera

A number of hedge funds have recently modified their holdings of the business. AIGH Capital Management LLC acquired a new stake in shares of Talphera during the 3rd quarter worth about $3,979,000. Rosalind Advisors Inc. lifted its position in Talphera by 118.9% in the third quarter. Rosalind Advisors Inc. now owns 4,385,757 shares of the company’s stock valued at $3,917,000 after buying an additional 2,381,818 shares during the last quarter. Nantahala Capital Management LLC boosted its stake in Talphera by 75.3% during the third quarter. Nantahala Capital Management LLC now owns 3,492,519 shares of the company’s stock worth $3,120,000 after buying an additional 1,500,000 shares during the period. Empery Asset Management LP acquired a new stake in shares of Talphera during the fourth quarter valued at about $1,520,000. Finally, Cantor Fitzgerald L. P. purchased a new stake in shares of Talphera in the 4th quarter valued at approximately $658,000. 37.67% of the stock is currently owned by hedge funds and other institutional investors.

Talphera Company Profile

Talphera, Inc, a specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings. Its lead product candidate is Niyad, a lyophilized formulation of nafamostat, which is under an investigational device exemption as an anticoagulant for the extracorporeal circuit. It is also developing LTX-608, an anti-inflammatory and antiviral potential for the treatment of multiple conditions, including disseminated intravascular coagulation (DIC), acute respiratory distress syndrome (ARDS), and acute pancreatitis; Fedsyra, a pre-filled ephedrine syringe; and PFS-02, a pre-filled phenylephrine syringe.